According to Kaplan-Meir plotter data, C1QA, C1QB, and C1QC mRNA expression was positively associated with a disease-free survival (DFS) rate in patients with BLBC (Figure 1C, p < 0.05) and with an overall survival (OS) rate with HER-2 positive cancers (Table 1). Here, ERBB2 is linked to cancer.